🇺🇸 FDA
Pipeline program

Placebo

T705aUS213

Phase 2 small_molecule completed

Quick answer

Placebo for Influenza is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Influenza
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials